insights_auto
Why is DUL down 3.54%?
Dive Deeperchevron_right
DUL:ETR
Alnylam Pharmaceuticals, Inc.
€ 196.30
arrow_downward
-3.54%(-7.20) 1D
10-р сарын 8, 17:35:48 (GMT+2) · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DUL...
Open
€ 200.20
High
€ 200.20
Low
€ 196.30
Mkt. cap
30.02 тэрбум
Avg. vol.
41.00
Volume
20.00
52-wk high
€ 417.40
52-wk low
€ 177.10
No. of employees
2 мян
Open
€ 200.20
High
€ 200.20
Low
€ 196.30
Mkt. cap
30.02 тэрбум
Avg. vol.
41.00
Volume
20.00
52-wk high
€ 417.40
52-wk low
€ 177.10
No. of employees
2 мян
News stories
From web sources and news partners
ChartMill
·
7 цагийн өмнө
Alnylam Pharmaceuticals (NASDAQ:ALNY): A Decent Value Stock Balancing Undervaluation and Growth
AD HOC NEWS
·
13 цагийн өмнө
Alnylam Pharmaceuticals stock gets a Strong Buy upgrade from Zacks Research
Trefis
·
3 өдрийн өмнө
Alnylam Pharmaceuticals Stock: 5 Straight Red Days, Down 14%
Profile
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals, Inc.